Neurovascular Pains: Implications of Migraine for the Oral and Maxillofacial Surgeon

Oral and Maxillofacial Surgery Clinics of North America

Volumn 20, Issue 2, 2008, Pages 221-235

  Nixdorf, Donald R ^a,b   Velly, Ana M ^a   Alonso, Aurelio A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIAL DIAGNOSIS; FACE PAIN; HUMAN; MIGRAINE; ORAL SURGERY; PATHOPHYSIOLOGY; REFERRED PAIN; REVIEW; SINUSITIS; TEMPOROMANDIBULAR JOINT DISORDER; TOOTH PAIN; TRIGEMINAL NERVE;

DIAGNOSIS, DIFFERENTIAL; FACIAL PAIN; HUMANS; MIGRAINE DISORDERS; PAIN, REFERRED; SINUSITIS; SURGERY, ORAL; TEMPOROMANDIBULAR JOINT DISORDERS; TOOTHACHE; TRIGEMINAL NERVE;

EID: 40649095002     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2007.12.008     Document Type: Review

References (111)

1. Graham J.R., and Wolff H.G. Mechanisms of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39 (1938) 737-763
2. Moskowitz M.A. The neurobiology of vascular head pain. Ann Neurol 16 2 (1984) 157-168
3. Woods R.P., Iacoboni M., and Mazziotta J.C. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 331 25 (1994) 1689-1692
4. Scher A.I., Stewart W.F., and Lipton R.B. Migraine and headache: a meta-analytic approach. In: Crombie I.K., Croft P.R., Linton S.J., et al. (Eds). Epidemiology of pain (1999), IASP Press, Seattle (WA) 159-170
5. Rasmussen B.K. Epidemiology of migraine. In: Olesen J., Goadsby P.J., Ramadan N.M., et al. (Eds). The headaches. 3rd edition (2006), Lippincott Williams & Wilkins, Philadelphia 235-242
6. Lipton R.B., Hamelsky S.W., and Stewart W.F. Epidemiology and impact of headache. In: Silberstein S.D., Lipton R.B., and Dalessio D. (Eds). Wolff's headache and other head pain. 7th edition (2001), Oxford Press, Oxford (UK) 85-107
7. Lipton R.B., Stewart W.F., Diamond S., et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41 7 (2001) 646-657
8. Hu X.H., Markson L.E., Lipton R.B., et al. Burden of migraine in the United States. Arch Intern Med 159 8 (1999) 813-818
9. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd edition. (ICHD-II). Cephalalgia 24 Suppl 1 (2004) 9-160
10. Silberstein S.D., Lipton R.B., and Dalessio D.J. Wolff's headache and other head pain. 7th edition (2001), Oxford Press, New York
11. Olesen J., Goadsby P.J., Ramadan N.M., et al. The headaches. 3rd edition (2006), Lippincott Williams & Wilkins, Philadelphia
12. Day J.W., and Raskin N.H. Thunderclap headache: symptoms of unruptured cerebral aneurysm. Lancet 29 2 (1986) 1247-1248
13. Rosenberg J.H., and Silberstein S.D. The headache of SAH responds to sumatriptan. Headache 45 5 (2005) 597-598
14. Saper J.R., Silbertstein S.D., Gordon C.D., et al. Handbook of headache management: a practical guide to diagnosis and treatment of head, neck, and facial pain. 2nd edition (1999), Lippincott Williams & Wilkins, Philadelphia p. 15-31
15. Kaniecki R.G. Diagnostic challenges in headache: migraine as the wolf in sheep's clothing. Neurology 58 Suppl 6 (2002) S1-S2
16. Welch K.M.A., and Goadsby P.J. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 15 3 (2002) 287-295
17. Silbertstein S.D., and Olesen J. Chronic migraines. In: Olesen J., Goadsby P.J., Ramadan N.M., et al. (Eds). The headaches. 3rd edition (2006), Lippincott Williams & Wilkins, Philadelphia 613-617
18. Mathew N.T., Reuveni U., and Perez F. Transformed or evolutive migraine. Headache 27 2 (1987) 102-106
19. Limmroth V., Katsarava Z., Fritsche G., et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59 7 (2002) 1011-1014
20. Bahra A., Walsh M., Menon S., et al. Does chronic daily headache arise de novo in association with regular use of analgesics?. Headache 43 3 (2003) 179-190
21. Bigal M.E., Sheftell F.D., Rapoport A.M., et al. Chronic daily headache: identification of factors associated with induction and transformation. Headache 42 7 (2002) 575-581
22. Young W.B., Richardson E.S., and Shukla P. Brush allodynia in hospitalized headache patients. Headache 45 8 (2005) 999-1003
23. Katsarava Z., Limmroth V., Finke M., et al. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 60 10 (2003) 1682-1683
24. Wang S.J., Fuh J.L., Lu S.R., et al. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology 68 8 (2007) 591-596
25. Dorland's illustrated medical dictionary. 27th edition (1988), Saunders, Philadelphia
26. Delcanho R.E., and Graff-Radford S.B. Chronic paroxysmal hemicrania presenting as toothache. J Orofac Pain 7 3 (1993) 300-306
27. Benoliel R., and Sharav Y. SUNCT syndrome: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 2 (1998) 158-161
28. Benoliel R., and Sharav Y. Paroxysmal hemicrania. Case studies and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 3 (1998) 285-292
29. Alonso A.A., and Nixdorf D.R. Case series of four different headache types presenting as tooth pain. J Endod 32 11 (2006) 1110-1113
30. Moncada E., and Graff-Radford S.B. Benign indomethacin-responsive headaches presenting in the orofacial region: eight case reports. J Orofac Pain 9 3 (1995) 276-284
31. Namazi M.R. Presentation of migraine as odontalgia. Headache 41 4 (2001) 420-421
32. Sarlani E., Schwartz A.H., Greenspan J.D., et al. Chronic paroxysmal hemicrania: a case report and review of the literature. J Orofac Pain 17 1 (2003) 74-78
33. Benoliel R., Elishoov H., and Sharav Y. Orofacial pain with vascular-type features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 5 (1997) 506-512
34. Czernisky R., Benoliel R., and Sharav Y. Odontalgia in vascular orofacial pain. J Orofac Pain 13 3 (1999) 196-200
35. Sharav Y., Benoliel R., and Elishoov H. Vascular orofacial pain: diagnostic features. 8th world congress on pain (1996), IASP Press, Seattle (WA) 155
36. Stewart W.F., Lipton R.B., Celentano D.D., et al. Prevalence of migraine headache in the United States. relation to age, income, race, and other sociodemographic factors. JAMA 267 1 (1992) 64-69
37. Lipton R.B., Diamond S., Reed M., et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41 7 (2001) 638-645
38. Pryse-Phillips W., Findlay H., Tugwell P., et al. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 19 3 (1992) 333-339
39. Rasmussen B.K., Jensen R., Schroll M., et al. Epidemiology of headache in a general population-a prevalence study. J Clin Epidemiol 44 11 (1991) 1147-1157
40. Launer L.J., Terwindt G.M., and Ferrari M.D. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 53 3 (1999) 537-542
41. Henry P., Michel P., Brochet B., et al. A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Cephalalgia 12 4 (1992) 229-237
42. Hagen K., Zwart J.A., Vatten L., et al. Prevalence of migraine and non-migrainous headache-head-HUNT, a large population-based study. Cephalalgia 20 10 (2000) 900-906
43. Lyngberg A.C., Rasmussen B.K., Jorgensen T., et al. Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol 161 11 (2005) 1066-1073
44. Breslau N., Davis G.C., and Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 37 1 (1991) 11-23
45. Edmeads J., Findlay H., Tugwell P., et al. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 20 2 (1993) 131-137
46. O'Brien B., Goeree R., and Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol 23 5 (1994) 1020-1026
47. Stewart W.F., Lipton R.B., and Liberman J. Variation of migraine prevalence by race. Neurology 47 1 (1996) 52-59
48. Breslau N., and Rasmussen B.K. The impact of migraine: epidemiology, risk factors, and co-morbidities. Neurology 56 Suppl 1 (2001) S4-S12
49. Schwartz B.S., Stewart W.F., Simon D., et al. Epidemiology of tension-type headache. JAMA 279 5 (1998) 381-383
50. Stewart W.F., Staffa J., Lipton R.B., et al. Familial risk of migraine: population-based study. Ann Neurol 41 2 (1997) 166-172
51. Ulrich V., Gervil M., Kyvik K.O., et al. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol 45 2 (1999) 242-246
52. Clarke J.M. On recurrent motor paralysis in migraine. BMJ 1 (1910) 1534-1538
53. 2+ channel gene CACNL1A4. Cell 87 3 (1996) 543-552
54. Ducros A., Denier C., Joutel A., et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 345 1 (2001) 17-24
55. Borroni G., Rao R., Liberini P., et al. Endothelial nitric oxide synthase (Glu298ASP) polymorphism is an independent risk factor for migraine with aura. Headache 46 10 (2006) 1575-1579
56. Scher A.I., Terwindt G.M., Verschuren W.M., et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 59 2 (2006) 372-375
57. Ferrari M.D., Nann J., and Palotie A. Genetics of migraine. In: Olesen J., Goadsby P.J., Ramadan N.M., et al. (Eds). The headaches. 3rd edition (2006), Lippincott Williams & Wilkins, Philadelphia 251-267
58. Göder R., Fritzer G., Kapsokalyvas A., et al. Polysomnographic findings in nights preceding a migraine attack. Cephalalgia 21 1 (2001) 31-37
59. Kelman L., and Rains J.C. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 45 7 (2001) 904-910
60. Spierings E.L., Ranke A.H., and Honkoop P.C. Precipitating and aggravating factors of migraine versus tension-type headache. Headache 41 6 (2001) 554-558
61. Wober C., Holzhammer J., Zeitlhofer J., et al. Trigger factors of migraine and tension-type headache: experience and knowledge of the patients. J Headache Pain 7 4 (2006) 188-195
62. Zwart J.A., Dyb G., Hagen K., et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 10 2 (2003) 147-152
63. MacGregor E.A., and Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63 2 (2004) 351-353
64. MacGregor E.A., Frith A., Ellis J., et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67 12 (2006) 2154-2158
65. Misakian A.L., Langer R.D., Bensenor I.M., et al. Postmenopausal hormone therapy and migraine headache. J Womens Health 12 10 (2003) 1027-1036
66. Breslau N., Lipton R.B., Stewart W.F., et al. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 60 8 (2003) 1308-1312
67. Loder E. Menstrual migraine: clinical considerations in light of revised diagnostic criteria. Neurol Sci 26 Suppl 2 (2005) S121-S124
68. MacGregor E.A. Oestrogen and attacks of migraine with and without aura. Lancet Neurol 3 6 (2004) 354-361
69. Shimshak D.G., Kent R.L., and DeFuria M. Medical claims profiles of subjects with temporomandibular joint disorders. Cranio 15 2 (1997) 150-158
70. Ciancaglini R., and Radaelli G. The relationship between headache and symptoms of temporomandibular disorder in the general population. J Dent 29 2 (2001) 93-98
71. LeResche L., Mancl L.A., Drangsholt M., et al. Predictors of onset of facial pain and temporomandibular disorders in early adolescence. Pain 129 3 (2007) 269-278
72. Von Korff M., Crane P., Lane M., et al. Chronic spinal pain and physical mental morbidity in the United States: results from the national comorbidity survey replication. Pain 113 3 (2005) 331-339
73. Hagen K., Einarsen C., Zwart J.A., et al. The co-occurrence of headache and musculoskeletal symptoms amongst 51,050 adults in Norway. Eur J Neurol 9 5 (2002) 527-533
74. Ifergane G., Buskila D., Simiseshvely N., et al. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 26 4 (2006) 451-456
75. Marcus D.A., Bernstein C., and Rudy T.E. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol 24 6 (2005) 595-601
76. Hestbaek L., Leboeuf-Yde C., Kyvik K.O., et al. Comorbidity with low back pain: a cross-sectional population-based survey of 12- to 22-year-olds. Spine 29 13 (2004) 1483-1491
77. El-Metwally A., Salminen J.J., Auvinen A., et al. Prognosis of non-specific musculoskeletal pain in preadolescents: a prospective 4-year follow-up study. Pain 110 3 (2004) 550-559
78. LeResche L., Mancl L., Drangsholt M., et al. Association of severe headache and migraine with TMD in adolescents. J Dent Res 85 A (2006) 114
79. Scher A.I., Bigal M.E., and Lipton R.B. Comorbidity of migraine. Curr Opin Neurol 18 3 (2005) 305-310
80. Rubinstein S.M., Peerdeman S.M., vanTulder M.W., et al. Hospital and population-based epidemiological studies have demonstrated the relationship between migraine and ischemic stroke. Stroke 36 7 (2005) 1575-1580
81. Kurth T., Gaziano J.M., Cook N.R., et al. Migraine and risk of cardiovascular disease in women. JAMA 296 3 (2006) 283-291
82. Lanzi G., Termine C., Rossi M., et al. Are vascular disorders more prevalent in the relatives of children and adolescents with migraine?. Cephalalgia 23 9 (2003) 886-891
83. Lipton R.B., Ottman R., Ehrenberg B.L., et al. Comorbidity of migraine: the connection between migraine and epilepsy. Neurology 44 Suppl 7 (1994) S28-S32
84. Marks D.A., and Ehrenberg B.L. Migraine-related seizures in adults with epilepsy, with EEG correlation. Neurology 43 12 (1993) 2476-2483
85. Velioglu S.K., and Ozmenoglu M. Migraine-related seizures in an epileptic population. Cephalalgia 19 9 (1999) 797-801
86. McWilliams L.A., Goodwin R.D., and Cox B.J. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 111 1-2 (2004) 77-83
87. Cutrer F.M. Pathophysiology of migraine. Semin Neurol 26 2 (2006) 171-180
88. Welch K.M. Contemporary concepts of migraine pathogenesis. Neurology 61 Suppl 4 (2003) S2-S8
89. Hargreaves R.J., and Shepheard S.L. Pathophysiology of migraine-new insights. Can J Neurol Sci 26 Suppl 3 (1999) S12-S19
90. Moskowitz M.A. Trigeminovascular system. Cephalalgia 12 3 (1992) 133-136
91. Fusco M., D'Andrea G., Micciche F., et al. Neurogenic inflammation in primary headaches. Neurol Sci 24 Suppl 2 (2003) S61-S64
92. Davidoff R.A. Migraine, manifestations, pathogenesis, and management. 2nd edition (2002), Oxford University Press, Oxford p. 228-73
93. Saxena P.R., and Tfelt-Hansen P. Triptans, 5-HT1B/D receptor agonists in acute treatment of migraines. In: Olesen J., Goadsby P.J., Ramadan N.M., et al. (Eds). The headaches. 3rd edition (2006), Lippincott Williams & Wilkins, Philadelphia 469-503
94. Strassman A.M., Raymond S.A., and Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384 6609 (1996) 560-564
95. Burstein R., Yamamura H., Malick A., et al. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79 2 (1998) 964-982
96. Burstein R., Yarnitsky D., Goor-Aryeh I., et al. An association between migraine and cutaneous allodynia. Ann Neurol 47 5 (2000) 614-624
97. Burstein R., Cutrer M.F., and Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123 Pt 8 (2000) 1703-1709
98. Drummond P.D. Scalp tenderness and sensitivity to pain in migraine and tension headache. Headache 27 1 (1987) 45-50
99. Smith R., Hasse L.A., and Vonder Meulen M.B. Scalp pain-threshold and early migraine treatment. Headache 44 5 (2004) 482
100. Moskowitz M.A., and Waeber C. Migraine enters the molecular era. Neuroscientist 2 3 (1996) 191-200
101. Fields H.L., and Basbaum A.I. Central nervous system mechanisms of pain modulation. In: Melzack R., and Wall P.D. (Eds). Textbook of pain. 3rd edition (1994), Churchill Livingstone, Edinburg (UK) 243-257
102. Bandler R., and Carrive P. Integrated defense reaction elicited by excitatory amino acid microinjection in the midbrain periaqueductal grey region of the unrestrained cat. Brain Res 439 1-2 (1988) 95-106
103. Raskin N.H., Hosobuchi Y., and Lamb S. Headache may arise from perturbation of brain. Headache 27 8 (1987) 416-420
104. Weiller C., May A., Limmroth V., et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1 7 (1995) 658-660
105. Welch K.M.A., Nagesh V., Aurora S.K., et al. Periaqueductal gray matter dysfunction in migraine: cause of the burden of illness?. Headache 41 7 (2001) 629-637
106. Qian J., and Noebels J.L. Presynaptic Ca2+ channels and neurotransmitter release at the terminal of a mouse cortical neuron. J Neurosci 21 11 (2001) 3721-3728
107. McGrail K.M., Phillips J.M., and Sweadner K.J. Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na,K-ATPase. J Neurosci 11 2 (1991) 381-391
108. Agosti R.M. 5HT1F- and 5HT7-receptor agonists for the treatment of migraines. CNS Neurol Disord Drug Targets 6 4 (2007) 235-237
109. Witkin J.M., Baez M., Yu J., et al. Constitutive deletion of the serotonin-7 (5-HT(7)) receptor decreases electrical and chemical seizure thresholds. Epilepsy Res 75 1 (2007) 39-45
110. Giffin N.J., and Kaube H. The electrophysiology of migraine. Curr Opin Neurol 15 3 (2002) 303-309
111. Cady R.K., Dodick D.W., Levine H.L., et al. Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin Proc 80 7 (2005) 908-916